Verify any claim · lenz.io
Claim analyzed
Health“Anemia is one of the most prevalent public health problems in Peru, especially among children under 5 years old.”
Submitted by Brave Bear 64b1
The conclusion
Anemia is clearly a major and highly prevalent health problem among young children in Peru, but the claim overstates what the evidence directly shows. National and international data support a high burden in children under 5, often around 30% nationally and higher in younger subgroups. What is not firmly established here is the broader comparative claim that anemia is 'one of the most prevalent public health problems' in Peru across all health conditions and populations.
Caveats
- The strongest evidence concerns children aged 6–59 months, not a nationwide ranking of anemia against all other public-health problems in Peru.
- Some of the highest cited prevalence figures refer to children under 3, while under-5 estimates are often lower.
- Measured anemia prevalence in Peru can vary meaningfully depending on diagnostic method and altitude adjustment, even though the overall burden remains high.
This analysis is for informational purposes only and does not constitute health or medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before making health-related decisions.
Get notified if new evidence updates this analysis
Create a free account to track this claim.
Sources
Sources used in the analysis
The World Bank indicator "Prevalence of anemia among children (% of children ages 6–59 months)" for Peru shows that roughly one quarter to one third of Peruvian children aged 6–59 months have anemia in recent years. For example, the series reports values around 30% in the late 2010s, indicating that anemia affects a large proportion of young children. The same page notes that the indicator is defined as the "percentage of children ages 6–59 months whose hemoglobin level is less than 11 grams per deciliter" and that the data source is the World Health Organization, Global Health Observatory.
“Currently in Peru 40.1% of children, from 6 to 35 months, suffer from anemia; that is, we are talking about almost 700 thousand anemic children under 3 years out of 1.6 million nationwide. This alarming situation has made the current government set as a goal to reduce it to 19% by 2021, through the National Plan to fight anemia.” The INS presents anemia in young children as one of the country’s main public health challenges.
“However, in 2024, the prevalence index of anemia in children between 6 to 35 months of age reached 43.7%, an increase of 3.6 percentage points compared to 2023.” The indicator is described as the percentage of children 6–35 months with anemia and is used to monitor the persistence of childhood anemia as a critical problem in Peru’s social development agenda.
WHO’s global estimates for 2021 state: “Anaemia is a major public health problem worldwide, affecting 571 million children under 5 years of age and 269 million women of reproductive age… In many low- and middle-income countries, anaemia in children under 5 years remains highly prevalent and of severe public health significance.” While this report provides global and regional estimates (including for the Americas), it notes that in several countries, anaemia in preschool-aged children is classified as a ‘severe public health problem’ (prevalence ≥40%).
“In Latin America and the Caribbean (LAC) in 2019, the prevalence of anemia in children under five was 21%… Likewise, in that same year in LAC, the highest prevalences were reported in Bolivia (37%) and Peru (30%), while the lowest were found in Costa Rica (19%), Argentina (19%), Cuba (18%) and Brazil (12%).” The authors report for Peru that “The prevalence of anemia in children under five years of age was 30.4% (CI: 29.5–31.3%) in 2019.” They add that “Children under five years of age have high nutritional demands and constitute a high-risk group for anemia… In Peru, it is estimated that around 30% of children under five years of age suffered from anemia in 2019, a figure higher than the LAC average (21%).”
The study notes that “Peru has one of the highest prevalences of childhood anemia throughout the Americas with historical estimates of anemia among young children aged 6–35 months as high as >70% in its highland regions and >40% across the country.” It explains that “Due to the high prevalence of childhood anemia in Peru, universal iron supplementation has been implemented by the government of Peru for infants under 5 years of age and pregnant women from 14 weeks of gestation.” In the Puno sample, “Applying the new WHO guidelines, anemia prevalence changed from 50% to 42.2% in children aged 6−59 months…”.
The abstract concludes: “Our findings reveal substantial changes in anemia prevalence among Peruvian children under 5 years of age depending on the diagnostic methods and altitude correction criteria applied.” While the exact percentages vary with method, the study describes anemia as common: multiple diagnostic approaches identify a large share of Peruvian under‑five children as anemic. The authors argue that this variability has important implications for “the assessment of anemia as a public health problem in Peru.”
The article states that “the presence of anemia in children from 6 to 59 months is defined as hemoglobin values less than 11 g/dL; these values were adjusted by altitude. The national average for rural areas in children 6–59 months is 39.5%.” It notes that childhood anemia in Peru affects a high proportion of under‑5 children and is linked to socioeconomic and nutritional factors, characterizing it as a major public health issue.
The paper notes that “prevalence of anemia worldwide is higher at 6–35 months of age, and reduced thereafter from 36 to 59 months. In Peru, after decreasing anemia in children 6–59 months from 56.8% in 1996 to 30.7% in 2011, it has remained at high levels. For the age group 6–35 months, anemia prevalence is high and around 60% between 6 and 11 months, then decreases to around 30% at 24–35 months.” The authors refer to childhood anemia in Peru as a condition with “high prevalence” and major public health implications.
The article states: “Among Latin American and Caribbean countries, the overall prevalence of anemia in children under 5 years was 28.4% in 2016. In Peru, despite the reduction in the prevalence of anemia from 37.7% in 2010 to 32.8% in 2018, anemia remains a major public health problem.” It further reports that “Nationwide, the prevalence of anemia is 29.57%, principally driven by rural areas. Puno (59.81%) and Cusco (46.37%) were the regions with the highest prevalence of anemia, while La Libertad (22.81%) and Lima (22.24%) were the regions with the lowest prevalence.” The authors conclude that “Anemia remains a public health concern, especially in high-risk zones such as rural areas. Peruvian children living in rural regions are the most affected…”.
The report states: “Globally 40% of children between 6–59 months, 37% of pregnant women, 30% in women of reproductive age present anemia… In Peru, despite efforts and financial investment, positive results have not been achieved and childhood anemia remains at levels above 40% in children between 6 and 36 months of age, with slight modifications during the last decade.” It adds that the prevalence in 2021 was 38.8% and in 2022 42.4%, and that the group with the highest level of anemia is children 6–18 months (54–65%).
“According to the Demographic and Family Health Survey (ENDES) of the National Institute of Statistics and Informatics (INEI), in 2024 the prevalence of anaemia and chronic malnutrition in children under five years increased to 43.7% and 12.1% nationwide, respectively: critical figures that reflect the food emergency currently faced by the child population… Thus, to chronic malnutrition is added iron-deficiency anaemia. According to the ENDES 2024 results, 43.7% of children under three years of age suffered from this disease in the last year nationwide… These statistics show the critical emergency that exists in Peru regarding the increase in the prevalence of anaemia and chronic child malnutrition, especially in a population made up of children between six months and five years of age.”
The report notes that anemia “continues to be a well-known public health problem in Peru. It is prevalent among a large proportion of young children and pregnant women, with previous estimates indicating that almost 30 per cent of children under age five and 21 per cent of women aged 15 to 49 years are anemic.” It also highlights socioeconomic gradients: “Peruvian National Censuses reveal an inverse relationship between household annual income and anemia rates in children under five years of age… Compounding the relationship between poverty and anemia is the ongoing political crisis in Peru.”
The WHO Global Health Observatory describes anemia as “a public health problem that affects low-, middle- and high-income countries and has significant health and economic consequences.” In its country data for Peru (selecting Peru in the visualization), WHO reports that roughly one quarter to one third of Peruvian children aged 6–59 months are anemic in recent years, a prevalence higher than the average for the Americas. The WHO categorizes anemia in children as a public health problem when prevalence exceeds 20%, and as a moderate to severe public health problem at higher levels, thresholds that Peru’s recent values meet or exceed.
“The sample included 20,160 children, with an anemia prevalence of 31.85%, with Puno and Tacna being the regions with the highest and lowest prevalence respectively. Mean hemoglobin was 11.4 ± 0.07 and age 31.71 ± 0.01 months; mild anemia was the most frequent (23.18%).” The authors conclude that several maternal-child factors are associated with anemia, reflecting its widespread occurrence among Peruvian children under 5.
The abstract describes the situation as follows: “In Peru, anemia in children under five years old continues to be a major public health challenge despite economic growth and the implementation of several national programs.” The authors report that national survey data show around one third of Peruvian under‑five children are anemic, with higher levels in rural and high‑altitude areas. They argue that this “high prevalence of anemia in Peruvian children under five years of age represents one of the main nutritional public health problems in the country.”
This 2024 study analyzing ENDES data reports that childhood anemia in Peru remains high. It notes that “in 2023, the boys affected by anemia were 53.1% and girls 46.9%” among children 6–59 months, and examines determinants such as region, wealth, and maternal education. The authors describe anemia in under‑5 children as a persistent and significant public health problem over the study period.
“In Peru, child health continues to face significant challenges. The latest results of the 2024 National Demographic and Health Survey (ENDES) reveal worrying data on the nutrition of children under 3 years. Childhood anaemia… recorded a notable increase, reaching 43.7% in this age group. In addition, chronic child malnutrition… also shows an upward trend, rising from 11.5% in 2023 to 12.1% in 2024 in children under 5 years.” The article notes that in some regions such as Puno the prevalence of anaemia in children under 3 exceeds 70%.
The 2019 Demographic and Family Health Survey (ENDES) reports national estimates of anemia in children: in the nutrition section, INEI states that approximately 30% of Peruvian children aged 6–59 months have anemia, based on hemoglobin levels below 11 g/dL adjusted for altitude. The report highlights marked disparities, with higher anemia prevalence in rural areas and highland regions compared with urban and coastal areas. INEI describes anemia in early childhood as a priority health issue that the Ministry of Health is targeting through supplementation and fortification programs.
Epidemiological reviews on Peru’s disease burden show that while anemia in children under 5 is highly prevalent and of major concern, other conditions such as respiratory infections, diarrheal diseases, and under‑5 mortality also rank prominently as public health problems. Some health‑policy commentaries argue that describing anemia as “one of the most prevalent public health problems in Peru” may overstate its ranking relative to these other burdens if interpreted across all ages and disease categories, even though anemia in young children is clearly widespread.
What do you think of the claim?
Your challenge will appear immediately.
Challenge submitted!
Continue your research
Verify a related claim next.
Expert review
3 specialized AI experts evaluated the evidence and arguments.
Expert 1 — The Logic Examiner
The evidence robustly supports that anemia prevalence among Peruvian under‑5s is high (about ~30% for ages 6–59 months in surveillance/analyses like Sources 1, 5, 14, 19, and often ≥40% for ages 6–35/36 months in Sources 2, 3, 11), and multiple institutions explicitly frame it as a major public-health challenge (Sources 2, 3, 10, 16). However, the claim's broader comparative phrasing (“one of the most prevalent public health problems in Peru”) is not logically established by prevalence-in-children data plus WHO threshold classifications (Sources 4, 14), because those do not demonstrate a cross-condition ranking against other major burdens; thus the claim is only partially supported and is best judged as misleading rather than clearly true or false.
Expert 2 — The Context Analyst
The claim is broadly supported for the under‑5 population (national surveys and institutional dashboards repeatedly show ~30% anemia in ages 6–59 months and >40% in ages 6–35/36 months in recent years), but it omits key framing context: “one of the most prevalent public health problems in Peru” is a comparative, all‑health‑conditions statement that is not directly established by the cited prevalence figures or WHO thresholds and could be read as ranking anemia above other major burdens (e.g., infectious diseases) (Sources 1, 3, 11, 14, 20). With full context, it's accurate that anemia is highly prevalent and a major public-health problem—especially among young children—but the “one of the most prevalent” nationwide framing is too broad/underspecified and can mislead about relative ranking across Peru's overall disease burden.
Expert 3 — The Source Auditor
The most authoritative sources in this pool—World Bank (Source 1), WHO (Sources 4 and 14), CEPLAN (Source 3), INS Peru (Source 2), INEI ENDES (Source 19), and multiple peer-reviewed studies in PubMed/PLOS ONE (Sources 5, 6, 7, 16)—all independently confirm that anemia affects roughly 30–44% of Peruvian children under 5, well above WHO's threshold for a severe public health problem, and that Peruvian institutions and international bodies consistently characterize it as one of the country's foremost child health challenges. The only source offering any refutation is Source 20, explicitly labeled as LLM background knowledge with low authority, which raises a comparative ranking caveat but does not cite independent data; this weak source cannot outweigh the overwhelming consensus from high-authority, independent, and recent sources, and the claim as scoped—'especially among children under 5'—is clearly and robustly confirmed by the evidence.
Expert summary
The arguments
Two AI advocates debated this claim using the research gathered.
Argument for
Multiple independent, high-authority datasets show anemia affects a very large share of Peruvian children under 5—around 30% nationally for ages 6–59 months (World Bank, Source 1; INEI ENDES 2019, Source 19; PLOS ONE 2019 analysis, Source 5) and exceeding 40% for the highest-risk 6–35/36 month group in recent years (INS, Source 2; CEPLAN 2024, Source 3; Colegio Médico del Perú, Source 11). By WHO public-health thresholds, prevalences above 20% constitute a public health problem and ≥40% are severe (WHO, Source 14; WHO estimates context, Source 4), so Peru's sustained ~30–44% levels—explicitly described as a major national challenge by Peruvian institutions and peer-reviewed studies (Sources 2, 3, 16)—justify the claim that anemia is one of the country's most prevalent public health problems, especially among under‑5s.
The Proponent's argument conflates high prevalence with being 'one of the most prevalent public health problems' overall, yet the sole source addressing comparative disease burden—Source 20—explicitly cautions that respiratory infections, diarrheal diseases, and under-5 mortality also rank prominently, meaning anemia's relative standing among all public health problems in Peru remains unestablished by the cited evidence. Moreover, the Proponent relies heavily on WHO thresholds from Source 14 to classify anemia as a 'severe' problem, but those thresholds speak to severity of anemia as a condition in isolation, not to its ranking relative to other competing public health burdens—a logical leap that does not rescue the claim from the comparative ambiguity Source 20 identifies.
Argument against
The claim that anemia is 'one of the most prevalent public health problems in Peru' is undermined by Source 20, which notes that other conditions such as respiratory infections, diarrheal diseases, and under-5 mortality also rank prominently as public health problems, suggesting the claim may overstate anemia's relative ranking across all age groups and disease categories. Furthermore, Source 7 explicitly highlights 'extreme variability' in anemia prevalence figures depending on diagnostic methods and altitude correction criteria, casting doubt on the reliability of the statistics used to elevate anemia to the status of 'one of the most prevalent' problems rather than simply a significant one among many.
The Opponent's argument hinges on Source 20—explicitly labeled as low-authority background commentary—while disregarding high-authority national and international surveillance showing anemia affects roughly 30% of Peruvian children 6–59 months (World Bank, Source 1; INEI ENDES, Source 19) and exceeds 40% in the highest-risk 6–35/36 month group (INS, Source 2; CEPLAN, Source 3; Colegio Médico del Perú, Source 11), which by WHO thresholds constitutes a moderate-to-severe public health problem (WHO GHO, Source 14; WHO estimates context, Source 4). The Opponent also commits a non sequitur with Source 7: methodological variability in measurement does not negate the consistent conclusion across datasets that prevalence remains high and widespread, and thus supports—rather than undermines—the characterization of anemia as one of Peru's most prevalent child public health problems (Source 7; Source 16).